8-K: Waystar Reports Strong Q1 2025 Results, Raises Full-Year Guidance

• Waystar Holding Corp. reported its first quarter 2025 financial results on April 30, 2025.
• The company achieved a 14% year-over-year revenue growth, reaching $256.4 million in Q1 2025.
• Net income for Q1 was $29.3 million, with a net income margin of 11%.
• Adjusted EBITDA stood at $107.7 million, representing an adjusted EBITDA margin of 42%.
• Waystar is raising its full-year revenue guidance to between $1.006 billion and $1.022 billion.
• The company also raised its adjusted EBITDA guidance to between $406 million and $414 million for the full year 2025.
• Non-GAAP net income is expected to be between $241 million and $247 million.
• Diluted non-GAAP net income per share is expected to be between $1.31 and $1.34.
• The company's net revenue retention rate (NRR) was 114% over the last twelve months (LTM) ending March 31, 2025.
• Subscription revenue increased by 18% year-over-year to $125.0 million.
• Volume-based revenue grew by 11% year-over-year to $129.9 million.

Score: 8

Explanation: The document presents a positive outlook with strong financial results, increased guidance, and strategic initiatives. The tone is optimistic and confident.

• Waystar achieved double-digit revenue growth for the fourth consecutive quarter as a public company.
• The company launched Waystar AltitudeAI, which provides clients with AI capabilities to streamline workflows and improve financial performance.
• The company has visibility and confidence to raise full-year revenue and adjusted EBITDA guidance.
• Net income margins exceeded 10% and adjusted EBITDA margins exceeded 40%.

• The company operates in a highly competitive industry.
• Waystar's ability to retain existing clients and attract new clients is crucial.
• Successful execution of business strategies is necessary for growth.
• Accurate risk assessment and successful integration of acquired businesses are important.
• Maintaining strategic relationships is essential.
• The company's performance is influenced by the growth and success of its clients and overall healthcare transaction volumes.
• Consolidation in the healthcare industry could pose challenges.
• The company's selling cycle can be of variable length.
• Implementation cycle depends on clients' timing and resources.
• Dependence on senior management and key employees is a risk.
• Accuracy of estimates and assumptions regarding the total addressable market is important.
• The company needs to develop and market new solutions to respond to technological changes.
• Interoperability, connectivity, and integration of solutions with clients' systems are crucial.
• Performance and reliability of internet and mobile infrastructure are important.
• The company must be able to obtain, process, use, disclose, and distribute highly regulated data.
• Reliance on third-party vendors and providers is a risk.
• Errors or malfunctions in products and solutions could have consequences.
• Clients must obtain proper permissions and provide accurate information.
• The company faces potential risks from embezzlement, identity theft, or other illegal behavior.
• Compliance with rules of the National Automated Clearing House Association and card network requirements is necessary.
• Increases in card network fees and other changes to fee arrangements could affect the company.
• Payer and provider conduct, which is beyond the company's control, can have an effect.
• Privacy concerns and security breaches or incidents relating to the platform are risks.
• The company must comply with complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity.
• The company needs to adequately protect and enforce its intellectual property rights.
• The company's ability to use or license data and integrate third-party technologies is important.
• The company uses open source software, which carries certain risks.
• Legal proceedings alleging infringement of intellectual property rights are a risk.
• Claims that employees have wrongfully used or disclosed confidential information are a risk.
• The company operates in a heavily regulated industry.
• The healthcare regulatory and political framework is uncertain and evolving.
• Healthcare laws and data privacy and security laws and regulations govern the processing of personal information.
• Changes to the healthcare regulatory landscape could reduce revenues.
• Legal, regulatory, and other proceedings could result in adverse outcomes.
• Consumer protection laws and regulations apply to the company.
• Contractual obligations require compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws.
• Existing laws regulate the company's ability to engage in certain marketing activities.
• The company must fully comply with website accessibility standards.
• Changes in tax rates, adoption of new tax legislation, or exposure to additional tax liabilities are risks.
• Limitations on the ability to use net operating losses to offset future taxable income could affect the company.
• Losses due to asset impairment charges are a risk.
• Restrictive covenants in credit facility agreements could limit the company's actions.
• Interest rate fluctuations could affect the company's financial performance.
• Unavailability of additional capital on acceptable terms is a risk.
• General macroeconomic conditions can have an impact.
• Actions of significant investors, who may have different interests, could affect the company.

Waystar expects full-year 2025 revenue to be between $1.006 billion and $1.022 billion and adjusted EBITDA to be between $406 million and $414 million.

• Waystar sustained strong momentum in the first quarter of 2025, delivering net income margins exceeding 10%, adjusted EBITDA margins exceeding 40%, and our fourth consecutive quarter of double-digit revenue growth as a public company, said Matt Hawkins, Chief Executive Officer of Waystar.
• We also advanced our innovation roadmap with the launch of Waystar AltitudeAI, equipping clients with powerful AI capabilities that streamline workflows and improve financial performance.
• With a resilient foundation and durable growth model, we have the visibility and confidence to raise our full-year revenue and adjusted EBITDA guidance.

Waystar's focus on healthcare payment software aligns with the industry's ongoing efforts to streamline financial processes and improve efficiency for healthcare providers. The launch of Waystar AltitudeAI reflects the increasing importance of AI in healthcare technology.

• Comparing Waystar's 14% revenue growth to peers like R1 RCM (historically around 10-15% growth) shows competitive performance.
• An adjusted EBITDA margin of 42% is strong, potentially exceeding that of companies like Change Healthcare before its acquisition.
• A net revenue retention rate of 114% indicates strong customer loyalty and upsell capabilities, which is a key metric for SaaS companies in the healthcare space.
• Companies like Veeva Systems often target NRR rates above 120%, suggesting Waystar has room for further improvement in this area.

• Shareholders will likely react positively to the strong financial results and increased guidance.
• Employees may benefit from the company's growth and success.
• Customers will benefit from the company's innovative solutions and improved financial performance.
• Suppliers may see increased business opportunities as the company grows.

• Waystar's financial results will be discussed on a conference call scheduled at 4:30 p.m. Eastern Daylight Time on April 30, 2025.
• Investors should monitor the Investor Relations section of the company's website for important information.

• 2025-02-18: Date of the Company's 10K filing with the SEC.
• 2025-03-31: End of the fiscal quarter for which results are reported.
• 2025-04-30: Date of the earnings release and conference call.